27 results on '"Hadzijusufovic E"'
Search Results
2. 198: ROBOTIC ASSISTED TRANS CERVICAL ESOPHAGECTOMY (RACE PROCEDURE): DESCRIPTION OF THE SURGICAL TECHNIQUE AND PRELIMINARY RESULTS
3. 149: CONVERSION DURING MINIMALLY INVASIVE ESOPHAGECTOMY DOES NOT AFFECT ONCOLOGICAL AND SURGICAL OUTCOMES
4. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)
5. 676 NECESSITY OF EXTENDED LOWER PARATRACHEAL LYMPH NODE RESECTION DURING ESOPHAGECTOMY FOR CANCER
6. Minimally invasive esophagectomy: clinical evidence and surgical techniques
7. P149 MINIMAL INVASIVE TEMPORARY GASTRIC ELECTRO STIMULATION - 1 YEAR FOLLOW
8. P123 ROBOT ASSISTED MINIMALLY INVASIVE ESOPHAGECTOMY (RAMIE4) WITH INTRATHORACIC ANASTOMOSIS: PROMISING RESULTS AND LESSONS LEARNED IN 100 PATIENTS
9. Temporäre Elektrostimulation des Magen – 1 Jahr Follow-Up
10. Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: a propensity-matched analysis
11. Innovative fully robotic 4-arm Ivor Lewis esophagectomy for esophageal cancer (RAMIE4)
12. Preoperative endoscopic pyloric balloon dilatation decreases the rate of delayed gastric emptying after Ivor–Lewis esophagectomy
13. Change from Hybrid to Fully Minimally Invasive and Robotic Esophagectomy is Possible without Compromises
14. Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
15. Umstieg von Hybrid Ösophagektomie zur total minimal-invasiven Ösophagektomie – a single center and single surgeon analysis
16. Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
17. Achalasia—an unnecessary long way to diagnosis
18. Proposed diagnostic criteria and classification of basophilic leukemias and related disorders
19. IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells
20. Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
21. Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia
22. TheKITD816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease
23. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy
24. Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
25. NI‐1: a novel canine mastocytoma model for studying drug resistance and IgER‐dependent mast cell activation
26. Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536
27. Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.